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Protein Structure-Directed Metal-Organic Zeolite-Like 
Networks as Biomacromolecule Carriers  
Huanrong Wang,[a],# Lin Han,[b],# Dong Zheng,[a] Mingfang Yang,[b] Yassin H. Andaloussi,[d] Peng Cheng,[b] 
Zhenjie Zhang,[a],[b] Shengqian Ma,[c] Michael J. Zaworotko,[d] Yifan Feng,[a] Yao Chen* [a],[e] 
Abstract: Fabrication of zeolite-like metal-organic frameworks 
(ZMOFs) for advanced applications such as enzyme immobilization is 
of great interest but represents a great synthetic challenge. Herein, 
we have developed a new strategy using proteins as structure-
directed agents to direct the formation of new ZMOFs that can act as 
versatile platforms for in-situ encapsulation of proteins under ambient 
conditions. Notably, protein incorporation directs the formation of a 
ZMOF with a sodalite (sod) topology instead of a non-porous 
diamondoid (dia) topology under analogous synthetic conditions. An 
in-depth investigation into the mechanism of the encapsulation 
process revealed that histidine moieties in proteins played a crucial 
role in the observed templating effect. Modulating histidine content 
thereby influenced the resultant MOF product (from dia to dia + sod 
mixture and, ultimately, to sod MOF). Moreover, the resulting ZMOFs 
incorporated proteins and preserved their activity even after the stress 
of high temperatures and organic solvents. Specifically, biocatalysis 
and biopharmaceutical formulation applications are enabled. This 
study demonstrates the first example, to our knowledge, of proteins 
as structure-directed agents for new crystalline metal-organic 
materials and paves the way for in-situ incorporation of 
biomacromolecules into porous materials for multiple applications. 
In the past decades, zeolite-like metal-organic framework 
(ZMOFs) (also referred to metal-organic zeolites, MOZs) have 
emerged as a metal–organic analogues of inorganic zeolites and 
represent an important subclass of MOFs because they can 
integrate the merits of both MOFs and zeolites.[1-3] These such as 
high porosity thanks to cage-like cavities,[2] designable pore 
window/shape,[4] customizable functionality[5] and exceptional 
stability.[6] ZMOFs have become an active fields of MOF chemistry 
as they offer potential utility for applications as diverse as gas 
storage/separation,[7] drug delivery,[8] sensing,[9] enzyme 
immobilization[10-13] and so on.[14-16] Theoretically, the number of 
ZMOFs is vast, as reflected by the high number in hypothetical 
zeolite topologies and the modular nature of MOFs 
databases.[17,18] However, ZMOFs are still rare among the 75,600 
MOF entries in version 5.38 of the Cambridge Structural 
Database. This is largely because the synthesis of ZMOFs 
requires control of network topology and functionality. This is 
difficult because the assembly of tetrahedral building blocks (i.e. 
the fundamental building blocks of zeolitic networks such as 
ZMOFs) tends to result in the default dia topology, which is not a 
zeolitic topology.  
Template-directed synthesis has proved to be a powerful 
strategy to obtain new ZMOFs that are otherwise inaccessible.[19] 
For example, the presence of different templates such as 1,2-
diaminocyclohexane, imidazole, 1,3,4,6,7,8-hexahydro-2H-
pyrimido[1,2-a]pyrimidine (HPP) afforded mer, sod and rho Z-
MOF topologies.[2,3] If the template(s) remains after MOF 
synthesis, additional functionalities, such as chirality,[20] 
catalysis[21] and fluorescence[22] can be transferred from 
templates to such ‘template@MOF’ materials (@ = encapsulated 
by). Until now, template molecules have typically comprised small 
inorganic,[23] organic[24] or organic-inorganic species[25] and the 
use of proteins as templating agents is yet to be reported. In 
polymer chemistry, proteins have been applied as removable 
templates to fabricate molecularly imprinted polymers (MIPs) 
which can be used for protein recognition.[26] These results 
inspired us to explore if proteins, especially bioactive enzymes, 
can indeed be used as templates to form new ZMOFs which can 
inherit the function of proteins (e.g. catalysis,[27,28] recognition and 
sensing[29]). In this study, we demonstrate the first example of the 
use of proteins as templates to direct the formation of a new 
ZMOF platform with zeolitic sodalite or sod topology (named 
hereafter ZPF-1, ZPF = zeolitic pyrimidine framework) (Scheme 
1). In contrast, the same experiment conducting in the absence of 
a protein template afforded the default dia network. ZPF-1 can 
thereby serve as a versatile platform for in-situ encapsulation of 
proteins with high loading capacity because the protein remains 
in the materials after synthesis. We also investigated the 
mechanism of templating to study the role of histidine groups on 
proteins in directing the target ZMOF structure. The discovery of 
the templating effect of proteins and a more developed 
understanding of the mechanism should provide guidance for the 
design and synthesis of a broad range of functional porous 
materials that incorporate biomacromolecules. 
Scheme 1.  Illustration of the template effect of proteins to direct the formation 
of new zeolitic frameworks (sod topology) encapsulating proteins instead of 
forming the default dia topology. Color code: carbon (gray), hydrogen (white), 
nitrogen (blue), metal (cyan) and oxygen (red). 
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Many MOFs are designed according to the ‘node and linker’ 
approach and elaborated using ‘reticular chemistry’.[30] The key 
design concept in generating the protein-encapsulating ZMOFs 
(e.g. ZIF-8 and ZIF-90)[10-12] is the tetrahedral geometry of the 
metal atoms (e.g. Zn2+) and a suitable subtended linker angle (e.g. 
142.4º for 2-R-imidazole, R = methyl or aldehyde). Pyrimidine 
derivatives are a basic building block of genetic material and 
possess structural similarity with the imidazole derivatives that 
generate ZIF-8 and ZIF-90. However, the use of pyrimidin-2-ol 
and zinc ions to generate ZMOFs has not been achieved via 
traditional synthesis methods, which afford the previously 
reported nonporous MOF (named herein DIA-1) with diamond 
morphology and dia topology (Figure S1). Herein, inspired from 
the protein template effect in formation of MIPs, we show that use 
of proteins as templates to modulate the reactions of pyrimidin-2-
ol and zinc cations is feasible, thereby preparing ZMOFs which 
encapsulate proteins.  
Bovine serum albumin (BSA) was selected as a model protein 
in this study on the basis of its low cost and high solubility. 
Presence of BSA during synthesis resulted in a new crystalline 
phase (named herein ZPF-1) in aqueous solution at room 
temperature. Fourier transform infrared spectroscopy (FT-IR) 
(Figure S2a) confirmed that successful encapsulation of BSA into 
ZPF-1 had occurred, indicated by the existence of characteristic 
peaks of BSA. Fluorescein isothiocyanate (FITC)-labeled BSA 
was also encapsulated by ZPF-1 and scanned by CLSM 
(Confocal Laser Scanning Microscopy, Figure S2b) to further 
verify that successful encapsulation of BSA had indeed occurred. 
Calculations based on the Bradford method revealed that the 
loading of BSA is as high as 0.2365 g/g. Powder X-ray diffraction 
(PXRD) and transmission electron microscopy (TEM) studies 
were conducted to further verify and investigate the template 
effect of BSA (Figure 1 and S3). Peak broadening observed in the 
PXRD pattern of BSA@ZPF-1 revealed the presence of 
nanometer-scale crystals, which were verified as such using TEM. 
As shown in Figure 1b, BSA@ZPF-1 possesses particles 
approximately 80 nm in size and polyhedral morphology whereas 
DIA-1 formed particles with dimensions on the order of 600 nm 
and prismatic morphology. Gas sorption data revealed the 
BSA@ZPF-1 exhibited a hierarchal structure with both ultra-micro 
pores originated from the structure nature of ZPF-1 and macro 
pores due to particle packing or defects (Figure S4). Additionally, 
the obtained MOF product was shown to be affected by the 
concentration of BSA. A mixture of BSA@ZPF-1 and DIA-1 was 
obtained when reducing the amount of BSA (<0.05 mg/mL) 
(Figure S5). These results show that BSA indeed exhibits a 
template effect that enables the formation of ZPF-1. 
 
Figure 1. (a) PXRD patterns of the BSA@ZPF-1 and DIA-1 compared with 
calculated patterns; (b) TEM images of DIA-1 (left), BSA@ZPF-1 (right). 
On the basis of the templating effect of BSA, we studied if other 
proteins can also serve as templates. The template effect was 
indeed broadly observed for proteins such as GOX (Glucose 
oxidase), Mb (Myoglobin), Insulin, CAT (Catalase), ACP (Acid 
phosphatase) and G-IgG (Goat anti BSA IgG polyclonal antibody), 
all of which templated the formation of ZPF-1 (Table S1) as 
verified by PXRD (Figure S6) and TEM (Figure S7). FT-IR 
spectroscopy results confirmed that proteins were successfully 
encapsulated into ZPF-1 (Figure S8). This broad performance 
across a range of proteins prompted us to investigate the 
mechanism behind the templating effect. As the basic building 
blocks of proteins, amino acids were first tested. After screening 
all 20 types of natural amino acids, we found that only histidine 
templated the formation of ZPF-1 (Figure S9) at room temperature 
from aqueous solution. Single crystal X-ray diffraction (SCXRD) 
data revealed that each zinc atom is four-coordinated in a 
tetrahedral geometry connected to bridging pyrimidin-2-ol ligands 
to generate a three-dimensional (3D) network with sod topology 
which resembles the structure of ZIF-8 and ZIF-90. Compared 
with the regular sod cages of ZIF-8 and ZIF-90, with inner cage 
diameters of approximately 7 Å, ZPF-1 possessed a smaller sod 
cage of approximately 6 Å diameter (Figure 2). PXRD analysis 
revealed that samples of protein@ZPF-1 matched the calculated 
pattern of ZPF-1 (Figure 1a and S6).  
 
Figure 2. Structural diagram of ZPF-1 vs. ZIF-8. Color code: carbon (gray), 
hydrogen (white), nitrogen (blue) and oxygen (red). 
We subsequently discovered that the amount of added histidine 
can affect the outcome. PXRD (Figure S10) tests revealed a 
mixture of DIA-1 and ZPF-1 when reducing the concentration of 
histidine. This effect is consistent with that observed for BSA. In 
order to exclude other possible factors that may affect the 
templating process (e.g. anions and metal-ligand ratio), we varied 
the zinc salts (e.g. ZnCl2, Zn(Ac)2, ZnSO4 and Zn(ClO4)2) and the 
ratios of reactants with no influence on the topology of the final 
product (Figure S11 and S12). Control reactions were performed 
whereby macromolecules without histidine moieties where added, 
such as organic polymers (polyethylene glycol (PEG), polyvinyl 
alcohol (PVA), polyvinylpyrrolidone K30 (PVP)), antibiotics 
(Streptomycin and Chloramphenicol) and inorganic particles 
(SiO2 and Fe3O4), all of which failed to generate the ZPF-1 product 
(Figure S13). These results reveal that the template effect of 
proteins originates from presence of histidine. 
We attribute these observations to histidine being an α-amino 
acid with an imidazole functional group. Indeed, histidine has 
already been incorporated into the sod network of ZIF-8 as a co-
ligand due to its similar coordination geometry to 2-methyl 
imidazole.[31,32] We found that 2-methyl imidazole can also 
template the formation of ZPF-1, once again indicative of the key 
role of imidazole moieties in the templating process (Figure S14). 
Thus, it is reasonable to assert that the imidazole moieties in 
histidine can form structural precursors of the sod network in the 
initial reaction stage and thereafter be substituted by excess 
pyrimidin-2-ol in the following step to generate the observed sod 
network (Scheme 2). If the above assertion is correct, the amount 
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templating effect. Thus, we treated BSA with diethyl 
pyrocarbonate (DEPC), a histidine-specific alkylating reagent 
(Figure 3a). As the alkylation reaction of DEPC progressed, the 
UV absorbance of BSA at 227 nm increased (Figure 3b). The 
absorbance at 227 nm had no obvious upward trend from 60 min 
to 120 min after DEPC treatment, indicating that the alkylation 
reaction had reached equilibrium at 60 min (Figure 3a and 3b). 
When DEPC-modified BSA was used as an additive in the 
reaction of pyrimidin-2-ol and zinc ions, DIA-1 was produced with 
the absence of ZPF-1 (Figure S15), indicating the need for 
histidine during the formation of ZPF-1. Furthermore, we 
expressed glutathione S-transferase (GST), a protein with 
histidine, and recombinant GST (rGST), a histidine free protein, 
in E. coli to directedly investigate the structure-directed role of 
histidine in proteins (Figure 3d). The purified GST and rGST were 
found to be ~99% pure as indicated by dodecyl sulfate, sodium 
salt (SDS)-Polyacrylamide gel electrophoresis (SDS-PAGE) 
(Figure S16). As predicted, GST produced the desired sod 
structure of ZPF-1, while rGST formed the structure of DIA-1 
(Tables S1 and Figure 3c). Besides, we found that addition of 
histidine as a co-template in the preparation of protein@ZPF-1 
can significantly increase the encapsulation efficiency of proteins 
in ZPF-1 (e.g. BSA encapsulation increased up to 31% in 
BSA@ZPF-1) (Table S2). These results revealed that histidine 
indeed plays a crucial role in the templating process of ZPF-1. 
 
Figure 3. (a) Reaction pathway of histidine imidazole groups with an excess of 
DEPC; (b) UV-Vis spectra of BSA reacted with 10 mM DEPC recorded at 0, 10, 
60, and 120 min; (c) The PXRD patterns of products after adding GST or rGST; 
(d) Modeled 3D structure of GST and rGST. His residues are shown in magenta 
and Lys residues mutated by histidine are presented in green. 
Scheme 2. A proposed process for the histidine templating effect in the 
generation of ZMOFs for protein encapsulating.  
  The successful incorporation of proteins into ZPF-1 offers 
potential for applications such as biocatalysis and 
biopharmaceutical formulation. CAT, a well-known biocatalyst, 
was selected as a representative enzyme to evaluate the 
performance of the protein@ZPF-1 platform. The catalytic 
activity of CAT@ZPF-1  was evaluated by tracking the change of 
H2O2 in solution over time (apparent rate constants, Kobs) (Figure 
S17). The results revealed that CAT@ZPF-1 possesses a high 
activity (Kobs=3.54×10-3 s-1) (Figure S18). The confinement of 
enzymes in MOFs is expected to provide protection against stress. 
We exposed CAT@ZPF-1 and free CAT to heat (70 ℃), organic 
solvent (methanol and DMF) and trypsin (an endopeptidase that 
cuts off the carboxyl side of the lysine and arginine residues in the 
polypeptide chain), respectively. As shown in Figure 4a, ZPF-1 
protected CAT retained >70% of its original activity under all 
tested conditions, while free CAT demonstrated a sharp decrease 
(65-99%) in enzyme activity under the same conditions (Figure 
4a). It is notable that CAT@ZPF-1 can nearly retain its full activity 
after the treatment of DMF and trypsin. Encouraged by the good 
stability of CAT@ZPF-1, we investigated recyclability, a critical 
performance metric for practical applications. It was found that the 
enzymatic activity of CAT@ZPF-1 exhibited no significant 
decrease after ten cycles (Figure 4b). CAT@ZPF-1 exhibited no 
leaching and retained its crystallinity after recycling catalytic 
experiments (Figure S19 and S20). 
 
Figure 4. (a) Activity of CAT and CAT@ZPF-1 after various treatments; (b) 
Recycling experiments of the degradation of H2O2 in the presence of 
CAT@ZPF-1; (c) Indirect ELISA assay results of free G-IgG and G-IgG released 
from G-IgG@ZPF-1; (d) Relative activity (compared with the original activity of 
free G-IgG) of G-IgG released from G-IgG@ZPF-1 after various treatments.  
 As important biopharmaceuticals, antibodies are a fast-
growing category of therapeutic proteins that often suffer from 
inferior biophysical stability.[33] G-IgG antibody was selected to 
probe the potential of the ZPF-1 system to protect antibodies and 
serve as a new biopharmaceutical formulation platform. An 
enzyme-linked immune sorbent assay (Elisa) was used to 
determine antibody activity. Our results revealed that G-IgG can 
be successfully encapsulated by ZPF-1 with high efficiency (0.32 
g/g), with the encapsulation process presenting no influence on 
antibody activity (Figure 4c). In addition, as verified by a Bradford 
assay, the encapsulated G-IgG can be completely released from 
ZPF-1 within 15 min. G-IgG@ZPF-1 and free G-IgG were 
exposed at 75 ℃ or to methanol to test the protection effect of 
ZPF-1. The results indicate that the unprotected G-IgG lost most 
of its activity (>70%) after treatment (Figure 4d). In contrast, G-
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after release from the MOF. These results highlight ZPF-1’s 
protective capabilities towards biomacromolecules, enabling it to 
serve as a versatile platform for biopharmaceutical formulation 
and storage. 
In conclusion, we herein demonstrate a new strategy for using 
proteins as structure-directed agents in order to tune the 
formation of ZMOFs to afford protein@ZPF-1, a material that can 
act as a versatile in-situ platform for protein encapsulation. To 
investigate the template mechanism, we first screened all 20 
natural amino acids, which revealed that histidine played a critical 
role during the formation of the sod network. We thus modified 
the amount of directly added histidine or the histidine content of 
proteins to exert control over the MOF product and produce a pure 
sod topology ZMOF with sufficient histidine. Conversely, less 
histidine resulted in a dia+sod mixture or pure dia product. We 
also directly compared the histidine-free rGST protein with 
histidine-containing GST protein, and found histidine indeed 
played a key role to control the formed MOF structure. In addition, 
adding histidine as a co-template during the preparation of 
protein@ZPF-1 significantly improved protein encapsulation 
efficiency. Moreover, as we demonstrated by control studies, the 
incorporation of proteins into ZPF-1 endowed protein@ZPF-1 
with properties suitable for utility in biocatalysis or 
biopharmaceutical formulation. It should be noted that proteins 
did not exhibit template effect in all previously reported 
protein@MOF systems such as ZIF-8 and ZIF-90 since these 
MOFs can be obtained without adding proteins in the identical 
conditions. This study opens a new avenue to prepare new 
ZMOFs which cannot be accessed by traditional approaches, and 
creates a versatile strategy for the highly efficient fabrication of 
protein immobilization matrixes for various advanced applications. 
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